BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14435423)

  • 1. A case of oxalate nephrocalcinosis and primary hyperoxaluria.
    PYRAH LN; ANDERSON CK; HODGKINSON A; ZAREMBSKI PM
    Br J Urol; 1959 Sep; 31():235-48. PubMed ID: 14435423
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary hyperoxaluria. I. Clinical and pathologic findings in a patient with calcium oxalate nephrocalcinosis.
    SHEPARD TH; CREIGHTON SA; KREBS EG; LEE LW; THULINE HC
    Pediatrics; 1960 Apr; 25():582-91. PubMed ID: 14445829
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrocalcinosis in a patient with primary hyperoxaluria type 2.
    Kemper MJ; Müller-Wiefel DE
    Pediatr Nephrol; 1996 Aug; 10(4):442-4. PubMed ID: 8865239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STUDIES ON PRIMARY HYPEROXALURIA. I. IN VIVO DEMONSTRATION OF A DEFECT IN GLYOXYLATE METABOLISM.
    FREDERICK EW; RABKIN MT; RICHIE RH; SMITH LH
    N Engl J Med; 1963 Oct; 269():821-9. PubMed ID: 14052264
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.
    Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL
    Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIMARY HYPEROXALURIA.
    SWARTZ D; ISRAELS S
    J Urol; 1963 Jul; 90():94-101. PubMed ID: 14047862
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary hyperoxaluria type 1 in Tunisian children.
    Gargah T; Khelil N; Youssef G; Karoui W; Lakhoua MR; Abdelmoula J
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):385-90. PubMed ID: 22382246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrocalcinosis due to primary hyperoxaluria: case report from Saudi Arabia.
    Hamdan J; Young M; Mathew R; Saadi AR
    Ann Trop Paediatr; 1985 Dec; 5(4):223-5. PubMed ID: 2418774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oxalate: a poorly soluble organic waste with consequences].
    Lu Y; Bonny O
    Praxis (Bern 1994); 2015 Mar; 104(7):353-9. PubMed ID: 25804778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [APROPOS OF A CASE OF OXALOSIS].
    FRIES D; TRAEGER J; FRANCOIS B; PELLET M; REVILLARD A
    J Urol Nephrol (Paris); 1963; 69():647-59. PubMed ID: 14094283
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
    Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRIMARY hyperoxaluria and oxalosis.
    Nutr Rev; 1959 Apr; 17(4):104-7. PubMed ID: 13644806
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of carboxyl-carbon atom of glycine into oxalate in a case of primary hyperoxaluria.
    SCOWEN EF; CRAWHALL JC; WATTS RW
    Lancet; 1958 Aug; 2(7041):300. PubMed ID: 13564824
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of glycine to oxalate in primary hyperoxaluria.
    CRAWHALL JC; SCOWEN EF; WATTS RW
    Lancet; 1959 Nov; 2(7107):806-9. PubMed ID: 13812730
    [No Abstract]   [Full Text] [Related]  

  • 16. PRIMARY HYPEROXALURIA.
    HOCKADAY TD; CLAYTON JE; FREDERICK EW; SMITH LH
    Medicine (Baltimore); 1964 May; 43():315-45. PubMed ID: 14170789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hereditary hyperoxaluria or oxalosis. Apropos of a case].
    Bayoudh F; Landthaler G; Hue G; Hecketsweiler B; Mallet E
    Ann Pediatr (Paris); 1989 May; 36(5):321-5. PubMed ID: 2742316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical features of primary hyperoxaluria in end-stage renal disease.
    Absy MM
    Am J Nephrol; 1991; 11(4):301-4. PubMed ID: 1799188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
    Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
    Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
    Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.